Nanolek

NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio features products both developed in-house and created with international partners. NANOLEK focuses on the prevention and treatment of socially significant diseases.

Today, the company is a leader in the production of pediatric vaccines in Russia. NANOLEK's diversified medicinal product portfolio features therapeutic areas including vaccines, drugs for treatment of HIV, cancer, and other diseases.

NANOLEK HAS A UNIQUE EXPERIENCE IN TECHNOLOGY TRANSFER AS PART OF OUR PARTNERSHIP WITH THE GLOBAL PHARMACEUTICAL LEADERS

• A modern fast-growing Russian biopharmaceutical company
• Partnership with global pharmaceutical leaders
• A committed team of professionals
• Unique experience in vaccine technology transfer, manufacturing, and commercialization
• A diversified product portfolio formed under strategic partnerships and proprietary developments
• A high-tech full-cycle production facility compliant with GMP and ISO 9001

>800employees, 35% of whom specialize in biotechnology

23products in the portfolio

>20products under development

MANUFACTURE OF VACCINES AND BIOLOGICAL DRUGS

• 42 Mpre-filledsyringes a year
• 35 Mvials a year(solutions/suspensions)
• 2 Mvials a year(lyophilized products)

PRODUCTION OF SOLID DOSAGE FORMS

• 4 Btablets a year
• 250 Mcapsules a year